Annals Of Nuclear Medicine

SCI SCIE

国际简称：ANN NUCL MED 参考译名：核医学年鉴

主要研究方向：医学-核医学非预警期刊审稿周期：偏慢,4-8周

《核医学年鉴》(Annals Of Nuclear Medicine)是一本由Springer Singapore出版的以医学-核医学为研究特色的国际期刊，发表该领域相关的原创研究文章、评论文章和综述文章，及时报道该领域相关理论、实践和应用学科的最新发现，旨在促进该学科领域科学信息的快速交流。该期刊是一本未开放期刊，近三年没有被列入预警名单。

3区中科院分区
Q2 JCR分区
126 年发文量
2.4 IF影响因子
未开放 是否OA
52 H-index
1987 创刊年份
Bimonthly 出版周期
English 出版语言

Annals of Nuclear Medicine is an official journal of the Japanese Society of Nuclear Medicine. It develops the appropriate application of radioactive substances and stable nuclides in the field of medicine.

The journal promotes the exchange of ideas and information and research in nuclear medicine and includes the medical application of radionuclides and related subjects. It presents original articles, short communications, reviews and letters to the editor.

[ 查看全部 ]

投稿咨询加急咨询

Annals Of Nuclear Medicine期刊信息

ISSN：0914-7187
出版语言：English
是否OA：未开放
E-ISSN：1864-6433
出版地区：JAPAN
是否预警：否
出版商：Springer Singapore
出版周期：Bimonthly
创刊时间：1987
开源占比：0.1821
Gold OA文章占比：28.48%
OA被引用占比：0.1234...
出版国人文章占比：0.08
出版撤稿占比：0
研究类文章占比：87.30%

Annals Of Nuclear Medicine CiteScore评价数据（2026年6月最新版）

CiteScore

SJR

SNIP

CiteScore 指数

4.2

0.611

0.904

学科类别	分区	排名	百分位
大类：Medicine 小类：Radiology, Nuclear Medicine and Imaging	Q2	123 / 361	66%

名词解释：CiteScore 是衡量期刊所发表文献的平均受引用次数，是在 Scopus 中衡量期刊影响力的另一个指标。当年CiteScore 的计算依据是期刊最近4年（含计算年度）的被引次数除以该期刊近四年发表的文献数。例如，2022年的 CiteScore 计算方法为：2022年的 CiteScore =2019-2022年收到的对2019-2022年发表的文件的引用数量÷2019-2022年发布的文献数量注：文献类型包括：文章、评论、会议论文、书籍章节和数据论文。

Annals Of Nuclear Medicine中科院评价数据

《新锐期刊分区表》（2026年3月发布）

Top期刊	综述期刊	大类学科		小类学科
否	否	医学	3区	RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING 核医学	3区

Annals Of Nuclear Medicine JCR评价数据

2025-2026年最新版

按JCI指标学科分区	收录子集	分区	排名	百分位
学科：RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING	SCIE	Q2	101 / 217	53.7
学科：RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING	SCIE	Q2	92 / 217	57.83

Annals Of Nuclear Medicine历年数据统计

影响因子

中科院分区

Annals Of Nuclear Medicine中国学者发文选摘

1、Comment on Subcutaneous/cutaneous uptake in the cancer-affected breast on 18F-FDG PET/CT: association with post-surgical prognosis in breast cance
Author: Chen, Likai; Huang, Zhixian

Journal: ANNALS OF NUCLEAR MEDICINE. 2026; Vol. 40, Issue 4, pp. 455-456. DOI: 10.1007/s12149-026-02185-1
2、The 68Ga-PSMA-11 PET/CT PRIMARY score for predicting pathological upgrading in ISUP grade group 1 prostate cancer: Methodological considerations and future direction
Author: Ruan, Tian

Journal: ANNALS OF NUCLEAR MEDICINE. 2026; Vol. , Issue , pp. -. DOI: 10.1007/s12149-026-02207-y
3、Letter to the editor: [18F]SMBT-1 PET quantification - methodological considerations and future direction
Author: Song, Qing; Li, Mengxing

Journal: ANNALS OF NUCLEAR MEDICINE. 2026; Vol. , Issue , pp. -. DOI: 10.1007/s12149-026-02203-2
4、Improvement of tumor-to-blood ratio of radioimmunoconjugates by poly(ethyleneimine)-containing chelating agen
Author: Huang, Zhixian; Chen, Lifeng

Journal: ANNALS OF NUCLEAR MEDICINE. 2026; Vol. , Issue , pp. -. DOI: 10.1007/s12149-026-02171-7
5、Application of SPECT/CT muscle imaging in determining the involved muscles in cervical dystoni
Author: Shen, Ting-Ting; Wang, Quan-Peng; Zhang, Qi-Lin; Wu, Qian-Chang; Wang, Jun; Liu, Jing; Mi, Bao-Ming; Luo, Wei-Feng

Journal: ANNALS OF NUCLEAR MEDICINE. 2026; Vol. , Issue , pp. -. DOI: 10.1007/s12149-026-02178-0
6、The diagnostic and therapeutic value of FDG PET/CT for infectious diseases in FUO/IUO patient
Author: Wu, Peixuan; Hao, Keji; Li, Yuan; Wang, Yue; Gao, Yan; Wang, Qian

Journal: ANNALS OF NUCLEAR MEDICINE. 2026; Vol. , Issue , pp. -. DOI: 10.1007/s12149-026-02190-4
7、Predictive value of metabolic parameters from PET/CT in adult multifocal Langerhans cell histiocytosi
Author: Shan, Hui-min; Chen, Tao; Fan, Wei

Journal: ANNALS OF NUCLEAR MEDICINE. 2026; Vol. , Issue , pp. -. DOI: 10.1007/s12149-026-02154-8
8、Outcome of MRI-Guided Single-Dose Iodine-131 for Graves' Hyperthyroidism with Large Goite
Author: Yan, Shangcheng; Chen, Xiansheng; Yan, Bing; Li, Xin; Cao, Zhen; Zhang, Pan; Wang, Yajun; Guo, Wenmei; Liu, Ziwen

Journal: ANNALS OF NUCLEAR MEDICINE. 2026; Vol. , Issue , pp. -. DOI: 10.1007/s12149-026-02163-7